PFM Health Sciences, LP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q4 2019. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2022$26,262,000
-9.1%
563,560
-14.5%
0.95%
-13.9%
Q2 2022$28,902,000
-38.5%
659,410
+1.5%
1.10%
-37.2%
Q1 2022$46,979,000
+19.4%
649,513
+33.9%
1.76%
+31.2%
Q4 2021$39,330,000
-14.0%
485,135
+23.5%
1.34%
-0.4%
Q3 2021$45,712,000
-34.1%
392,786
-6.2%
1.34%
-38.2%
Q2 2021$69,407,000
+11.8%
418,645
-5.9%
2.18%
+14.8%
Q1 2021$62,060,000
+14.9%
444,877
+42.6%
1.90%
-0.3%
Q4 2020$53,997,000
+21.8%
311,940
-2.0%
1.90%
-7.3%
Q3 2020$44,330,000
+256.2%
318,232
+205.5%
2.05%
+217.3%
Q2 2020$12,446,000
-81.7%
104,180
-81.9%
0.65%
-80.0%
Q4 2019$67,840,000
+99.1%
577,163
+45.6%
3.23%
+221.2%
Q3 2019$34,067,000
-36.8%
396,270
-52.3%
1.01%
-1.7%
Q2 2019$53,863,000
+19.5%
830,834
+15.2%
1.02%
+2.7%
Q1 2019$45,084,000
+108.5%
721,229
+29.7%
1.00%
+73.2%
Q4 2018$21,627,000
+97.5%
556,095
+376.0%
0.58%
+109.9%
Q1 2017$10,948,000116,8360.27%
Other shareholders
NEVRO CORP shareholders Q4 2019
NameSharesValueWeighting ↓
BRAIDWELL LP 1,776,368$34,141,7931.08%
ARMISTICE CAPITAL, LLC 3,456,000$66,424,3201.02%
Palo Alto Investors LP 386,832$7,434,9110.70%
Rock Springs Capital Management LP 1,211,600$23,286,9520.62%
ArrowMark Colorado Holdings LLC 2,468,110$47,437,0740.58%
TD Capital Management LLC 84,648$1,626,9350.20%
Venator Management LLC 25,000$480,5000.18%
DAFNA Capital Management LLC 28,000$538,1600.17%
FRED ALGER MANAGEMENT, LLC 1,053,812$20,254,2660.12%
Counterpoint Mutual Funds LLC 6,844$131,5420.11%
View complete list of NEVRO CORP shareholders